Your English writing platform
Discover LudwigExact(60)
There were no differences among groups in other efficacy parameters.
There was no significant effect of 4030W92 on any other efficacy measure.
No statistically significant differences in the comparisons between groups, except for FEF25 (P=0.044), were observed in any of the other efficacy variables.
Individual patient data from these studies were combined to provide overall estimates of treatment effect for morning PEF and other efficacy measures.
Similarly, no significant differences were observed with tiagabine on the other efficacy outcome measures (described above) compared with placebo.
Other efficacy parameters, including changes from baseline in FVC, DLCO, and HRCT/fibrosis score, were exploratory endpoints.
Other efficacy end-points also showed improvement.
All other efficacy assessments were secondary efficacy end points.
BoNTA and placebo differed significantly on all other efficacy measures.
Other efficacy end points were analyzed using descriptive statistics (n ).
Other efficacy assessments are changes of TCM symptoms and toxicity.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com